These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 8712691

  • 1. Evidence for the release of autocrine growth factor(s) by Hodgkin's cell lines.
    Imam SA, Taylor CR.
    Anticancer Res; 1996; 16(4A):1727-32. PubMed ID: 8712691
    [Abstract] [Full Text] [Related]

  • 2. Purification and characterization of a Hodgkin's and B cell-associated glycoprotein.
    Wan KR, Wang MJ, Taylor CR, Imam SA.
    Anticancer Res; 1999; 19(4B):3275-81. PubMed ID: 10652624
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
    Imam A, Stathopoulos E, Holland SL, Epstein AL, Taylor CR.
    Cancer Res; 1990 Mar 01; 50(5):1650-7. PubMed ID: 1689214
    [Abstract] [Full Text] [Related]

  • 4. BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells.
    Imam A, Stathopoulos E, Taylor CR.
    Anticancer Res; 1990 Mar 01; 10(4):1095-104. PubMed ID: 1696446
    [Abstract] [Full Text] [Related]

  • 5. Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung.
    Cavanaugh PG, Nicolson GL.
    Cancer Res; 1989 Jul 15; 49(14):3928-33. PubMed ID: 2544264
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA, Talks KL, Turley H, Debnam P, Tan DC, Mariatos G, Gorgoulis V, Kittas C, Gatter KC.
    J Pathol; 2002 Aug 15; 197(5):677-83. PubMed ID: 12210089
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM, Shahsafaei A.
    Mod Pathol; 1996 Oct 15; 9(10):959-65. PubMed ID: 8902831
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
    Alas S, Emmanouilides C, Bonavida B.
    Clin Cancer Res; 2001 Mar 15; 7(3):709-23. PubMed ID: 11297268
    [Abstract] [Full Text] [Related]

  • 14. Characterization and expression of CT45 in Hodgkin's lymphoma.
    Heidebrecht HJ, Claviez A, Kruse ML, Pollmann M, Buck F, Harder S, Tiemann M, Dörffel W, Parwaresch R.
    Clin Cancer Res; 2006 Aug 15; 12(16):4804-11. PubMed ID: 16914565
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease.
    Wahl AF, Klussman K, Thompson JD, Chen JH, Francisco LV, Risdon G, Chace DF, Siegall CB, Francisco JA.
    Cancer Res; 2002 Jul 01; 62(13):3736-42. PubMed ID: 12097283
    [Abstract] [Full Text] [Related]

  • 17. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH.
    Hum Pathol; 2005 Jan 01; 36(1):10-5. PubMed ID: 15712176
    [Abstract] [Full Text] [Related]

  • 18. [Autocrine growth factor produced by a human promyelocytic leukemia cell line].
    Kasuga M, Yamanouchi T, Asano T, Tsushima T, Takaku F.
    Gan To Kagaku Ryoho; 1986 Apr 01; 13(4 Pt 2):1410-5. PubMed ID: 3460526
    [Abstract] [Full Text] [Related]

  • 19. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.
    Voorzanger N, Touitou R, Garcia E, Delecluse HJ, Rousset F, Joab I, Favrot MC, Blay JY.
    Cancer Res; 1996 Dec 01; 56(23):5499-505. PubMed ID: 8968107
    [Abstract] [Full Text] [Related]

  • 20. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC, Valente G, Kerim S, Navone R, Onesti P, Chiusa L, Resegotti L, Palestro G.
    Haematologica; 1997 Dec 01; 82(3):281-5. PubMed ID: 9234572
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.